Skip to content
Whale Atlas — Follow the signal.
Home
FULL RECORDS
Search insider filingsAll Congress filings
MORE TOOLS
WatchlistGold IntelligencePeopleCharts & technicalsCompany financialsOfficial newsMy saved workspace
YOUR RESEARCH
HomeSearch insider filingsAll Congress filings
More research tools
ExploreGold IntelligencePeopleInvestigate an ideaCharts & technicalsMore evidenceCompany financialsOfficial newsMy research & helpWatchlistMy saved workspaceLearn the basicsHow signals workData & coverage
RESOURCES
LearnMethodologyData sources
Built on public evidence.

Primary sources. Clear reasoning.
No black boxes.

Our approach
Public research workspacev1.0

Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…

HomeSearchCongressWatchlist
© 2026 Whale AtlasFree public-filing research. Not financial advice. By using this site you agree to the Terms of Use.
FAQCompare trackersMethodologyData & correctionsTermsPrivacy
LOOK INSIDE THE BUSINESS

Company financials.

Explore company-wide revenue, income and balance-sheet facts directly from SEC filings.

View ABEO insider activity ↗

ABEOABEONA THERAPEUTICS INC.

THE LATEST REPORTED YEAR

The company reported a profit.

$71.18M net income for the year ended December 31, 2025. These are reported results, not a forecast or a stock recommendation.

Revenue$5.82MYear ended December 31, 2025
Profit or loss$71.18MYear ended December 31, 2025
Cash from the business-$76.33MYear ended December 31, 2025
Total assets$179.51MAs of June 30, 2026
Total liabilities$51.45MAs of June 30, 2026
Cash & equivalents$56.23MAs of June 30, 2026
THE BUSINESS BEHIND THE TICKER

Revenue, over time.

Latest-filed standard financial facts · USD

$837K
2017-12
$3M
2018-12
$10M
2020-12
$3M
2021-12
$1.41M
2022-12
$3.5M
2023-12
$5.82M
2025-12

Bars show magnitude; labels retain the sign. Each observation covers a reported annual period of 330–400 days; transition years can differ.

From the filing

Reported periods can differ from calendar years. Later filings may restate earlier figures. These are company-wide facts; product and geographic revenue segments are not included.

Reported periodReported valueFiledSource
January 1, 2025 – December 31, 2025$5,820,000March 17, 202610-K ↗
January 1, 2023 – December 31, 2023$3,500,000March 20, 202510-K ↗
January 1, 2022 – December 31, 2022$1,414,000March 18, 202410-K ↗
January 1, 2021 – December 31, 2021$3,000,000March 29, 202310-K ↗
January 1, 2020 – December 31, 2020$10,000,000March 31, 202210-K ↗
January 1, 2018 – December 31, 2018$2,998,000March 16, 202010-K ↗
January 1, 2017 – December 31, 2017$837,000March 16, 202010-K ↗
Source and calculation details

One standard US-GAAP or IFRS concept is selected per metric, using USD only. Annual durations must be 330–400 days. Quarterly durations must be 70–110 days; year-to-date totals are excluded, and fourth quarters are never inferred by subtraction. Cash-flow quarters can therefore be sparse. Conflicting values filed on the same day are excluded. Latest-filed values are used, so these observations must not be treated as facts known in an earlier backtest.

Concept: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · Retrieved October 8, 2026

Response SHA-256: 636768f46653d2a6ef88c7a2f3600aa36414b265029032bf07e61c32ce5542a2

SEC company facts

Company-wide USD figures from SEC filings. Each card keeps its own reporting date; later filings can revise earlier results.